We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "
H1B Visa Data Search Tool"
In-Vitro Diagnostic Substance Manufacturing (NAICS code 325413) has an average growth rate of
0.87% as an H1B industry with
322
employees hired as of 2024
The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where 6 employees were hired. They peaked in 2023 with 43 employees, and the recent trend shows the average number of employees on an incline.
The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where the average salary was $49,299. The industry peaked in 2023 with an average salary of $97,967, and the recent trend shows the average salary on an incline.